A New Chapter for Mesenchymal Stem Cells: Decellularized Extracellular Matrices

被引:0
作者
Yagiz Anasiz
Riza Koksal Ozgul
Duygu Uckan-Cetinkaya
机构
[1] Hacettepe University,Department of Stem Cell Sciences, Graduate School of Health Sciences
[2] Hacettepe University,Stem Cell Research and Application Center (PEDI
[3] Hacettepe University,STEM)
[4] Hacettepe University,Pediatric Metabolism Unit, Institute of Child Health
来源
Stem Cell Reviews and Reports | 2017年 / 13卷
关键词
Mesenchymal stem cell; Extracellular matrix; Decellularization; Tissue engineering; Regenerative medicine;
D O I
暂无
中图分类号
学科分类号
摘要
From orthopedic to neurological disorders, stem cells are used as platforms to understand disease mechanisms and considered as novel and promising treatment options, especially when the valid therapeutic approaches are unavailable or ineffective. There are different stem cell types in the literature, however the spindle-shaped, colony forming and multilineage-differentiating cells, also known as mesenchymal stem cells (MSC) are very popular, as MSC can be isolated from different tissues with minimal ethical concerns and without tumor formations, which make them easily accessible and widely used in vitro and in vivo studies. In the literature, MSC have been shown to have therapeutic effects and orchestrate the healing process via their mobilization, migration, differentiation capacities, immunomodulation properties and/or secretion of bioactive factors. Nowadays, MSC derived extracellular matrices (ECM), which are part of the secreted/produced bioactive molecules from MSC; draw attention of researchers due to their key roles in cell biology. Several groups have isolated ECM from in vitro cultured MSC using different methods of decellularization techniques for tissue-engineering approaches. According to current knowledge, decellularized ECM (dECM) influence growth, adhesion, differentiation, migration, apoptosis, proliferation, and phenotype of cells, covering almost all cellular events. In this comprehensive review we focused on MSC and the isolation methods and effects of MSC derived dECM (MSC-dECM).
引用
收藏
页码:587 / 597
页数:10
相关论文
共 282 条
[1]  
Rubin LL(2011)Stem cell biology and drug discovery BMC Biology 9 42-688
[2]  
Haston KM(2014)Emerging approaches in predictive toxicology Environmental and Molecular Mutagenesis 55 679-801
[3]  
Zhang L(2008)Using stem cells and reprogramming to understand disease Regenerative Medicine 3 799-3744
[4]  
Eggan K(2006)The journey of developing hematopoietic stem cells Development 133 3733-92
[5]  
Mikkola HK(2014)Pluripotent stem cells in regenerative medicine: challenges and recent progress Nature Reviews. Genetics 15 82-39
[6]  
Orkin SH(2014)The global landscape of stem cell clinical trials Regenerative Medicine 9 27-145
[7]  
Tabar V(2014)MSC-based product characterization for clinical trials: an FDA perspective Cell Stem Cell 14 141-754
[8]  
Studer L(2013)Mesenchymal stem cells: a new trend for cell therapy Acta Pharmacologica Sinica 34 747-60
[9]  
Li MD(2016)The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells Cytokine 85 51-1643
[10]  
Atkins H(2008)Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo Hepatology 47 1634-1174